Displaying drugs 14226 - 14250 of 14693 in total
DG051
DG051 is a novel small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H), the protein made by one of the genes in the leukotriene pathway that has been shown to link to risk of heart attack. DG051 is designed to decrease risk of heart attack by decreasing the production of leukotriene B4...
Investigational
Matched Description: … attack by decreasing the production of leukotriene B4 (LTB4), an end product of the leukotriene pathway and …
4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN
Experimental
Lortalamine
Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental
Norclobazam
Investigational
4-Flourobenzenesulfonamide
Experimental
AL5424
Experimental
AL7089A
Experimental
Undecyl-Phosphinic Acid Butyl Ester
Experimental
Benzylamine
Experimental
Displaying drugs 14226 - 14250 of 14693 in total